Evidence map›Paper›PMID 42853422›Full record

ArticleActa neuropathologica2026

Multiple motor proteins regulate TDP-43 anterograde axonal transport.

Monica Feole, Victorio M Pozo Devoto, Neda Dragišić, Maria Čarna, Katja Klosterman, Clara Limbaek-Stokin, Giancarlo Forte, Kenneth L Moya, Richard A Smith, Clive N Svendsen and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neuropathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Monica FeoleThe Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Victorio M Pozo DevotoInternational Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
Neda DragišićCentral European Institute for Technology at Masaryk University, Brno, Czech Republic.
Maria ČarnaCentral European Institute for Technology at Masaryk University, Brno, Czech Republic.
Katja KlostermanUniversity of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
Clara Limbaek-StokinDepartment of Neuropathology and Ocular Pathology, Oxford University, Oxford, UK.
Giancarlo ForteInternational Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
Kenneth L MoyaCentre Interdisciplinaire de Recherche en Biologie (CIRB), Collège de France, Paris, France.
Richard A SmithCenter for Neurologic Study in La Jolla, La Jolla, CA, USA.
Clive N SvendsenThe Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Gorazd B StokinInstitute for Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic. gbstokin@alumni.ucsd.edu.

Funding

The European Union: Next Generation EU LX22NPO5107The Ministry of Education, Youth, and Sports Czech Republic-EATRIS CZ LM202305
6 · The paper itself

Abstract

TAR DNA-binding protein 43 (TDP-43) is an RNA-binding protein essential for RNA metabolism. Under physiological conditions, it predominantly resides in the nucleus but is also expressed in the cytoplasm, where it regulates mRNA trafficking and local translation. In nearly 97% of amyotrophic lateral sclerosis (ALS) cases, TDP-43 undergoes nuclear depletion and cytoplasmic aggregation. While its nuclear functions are well characterized, its axonal roles remain poorly understood, despite axonal degeneration being a hallmark of ALS pathology. To address this gap, we investigated TDP-43 localization and transport dynamics in axons of H9-derived human neurons. We compared fluorescently labeled TDP-43 with three well-characterized axonal cargoes, ras-related protein Rab5, synaptophysin, and amyloid precursor protein, and examined protein-protein interactions between TDP-43 and the axonal transport machinery. Our analyses revealed that TDP-43 exhibits active anterograde axonal transport and interacts with multiple kinesin motor proteins, including all three KIF5 isoforms, through the adaptor KLC1, and the synaptic vesicles motor KIF1A. This multi-motor engagement suggests a flexible transport system that ensures mRNA delivery to distal axons. In ALS, where TDP-43 accumulates abnormally in the cytoplasm, this flexibility may become compromised, with multiple transport mechanisms simultaneously affected. This could contribute to progressive accumulation of non-functional TDP-43 granules, disrupting mRNA trafficking and local translation. Our findings provide a foundation for understanding how physiological TDP-43 transport mechanisms may be impaired during disease, highlighting axonal TDP-43 transport pathways as potential therapeutic targets.

Indexed as

Axonal TransportAxonsDNA-Binding ProteinsNeuronsAmyloid beta-Protein PrecursorAmyotrophic Lateral SclerosisAnimalsHumansKinesinsrab5 GTP-Binding ProteinsSynaptophysinAmyloid beta-Protein PrecursorDNA-Binding ProteinsKinesinsrab5 GTP-Binding ProteinsSynaptophysinTARDBP protein, humanAdaptorsAmyotrophic lateral sclerosisAxonal transportCargoesMotor proteinsTDP-43

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.